• Inveon Performance
  • PET Technology
    • Highest Resolution
    • Largest Axial Field of View
    • Superior Countrate Performance
    • Unmatched Sensitivity
  • CT Technology
    • Highest Resolution
    • Large Field of View
    • Automated Zoom Control
    • Real-time Reconstruction
  • SPECT Technology
    • Highest Resolution
    • Unmatched Sensitivity
    • Automated Zoom Control
    • Versatile Configurations
  • Multimodality Integration
• Inveon Versatility
  • Dedicated PET System
  • Multimodality System
    • Dockable Option
• Inveon Workflow
  • Inveon Acquisition Workplace
  • Inveon Research Workplace
    • Pharmacokinetic Analysis
    • Multimodality 3D Visualization Workflow

From the first commercial preclinical system to the first hybrid scanners, Siemens has introduced every innovation in the field.

From basic science all the way through clinical trials, preclinical molecular imaging removes the limitations and enables you to see biological processes in complex living organisms in a whole new way.

The preclinical imaging primer developed by David Stout, Ph.D., Director, UCLA Crump Imaging Center, is designed to help new and experienced researchers gain insight into the benefits of investigating biological and structural features in living animals.

“Preclinical imaging using Siemens preclinical PET and CT technology enables rodent research with sufficient resolution and sensitivity to characterize the metabolic and structural signatures of various disease models. By combining molecular Imaging techniques and probes that are directly applicable to the clinical environment, we can easily facilitate the translation of our findings into patient diagnosis and care.”

David Stout, Ph.D.
Director, UCLA Crump Imaging Center
Crump Institute for Molecular Imaging